Biotechnology News and Research

RSS

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Brooks instrument unveils mass flow controllers built specifically for biotech applications

Brooks Instrument, a world leader in advanced flow, pressure, vacuum and vapor delivery solutions, has introduced two new mass flow controller (MFC) models designed specifically for biotechnology applications: the SLA5800 Series Biotech and the SLAMf Series Biotech.

From Brooks Instrument 7 Aug 2019

Freiburg start-up company takes over publicly traded company ‘CELLINK AB’

The idea of developing a laboratory instrument that handles and sorts individual, viable cells has been realized by researchers in the Laboratory for MEMS Applications in the Department of Microsystems Engineering at the University of Freiburg.

7 Aug 2019

LUCA Biologics develops live biotherapeutics for unmet medical needs in women's health

LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist.

6 Aug 2019

Greene Tweed highlights custom-engineered sealing solutions for pharmaceutical processing

Greene Tweed, a leading global manufacturer of high-performance seals, thermoplastics, composites, and engineered components, highlights its sealing solutions for pharmaceutical processing.

6 Aug 2019

Seaweed and kelp have potential to provide great money-making opportunities

Products from kelp have the potential to provide great money-making opportunities, but we need to know more about these possibilities before we can use them.

6 Aug 2019

New research explains why some cancers don't respond to immunotherapy

New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called "checkpoint inhibitors" or anti-PD-1.

6 Aug 2019

United States and China should collaborate, not compete, to take advantage of AI in healthcare

In the wake of the U.S. government ordering the Chinese artificial intelligence company iCarbonX to divest its majority ownership stake in the Cambridge, Mass.-based company PatientsLikeMe, Eric Topol, M.D., of Scripps Research, argues for more, not less, collaboration between China and the U.S. on artificial intelligence development.

3 Aug 2019

New stem cell combination may help repair damage caused by heart attack

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.

2 Aug 2019

New liquid biopsy chip captures circulating tumor cells with greater sensitivity

Researchers at Worcester Polytechnic Institute have developed a chip made of carbon nanotubes that can capture circulating tumor cells of all sizes and types, and can do so with far greater sensitivity than existing technologies.

1 Aug 2019

New staffing model based on team approach for specialist palliative care

The Canadian Society of Palliative Care Physicians has developed a new staffing model for specialist palliative care teams that can deliver an optimal, integrated palliative care program.

1 Aug 2019

Study reveals the complexities of viral evolution

Comparing a living cell to a virus is a bit like comparing the Sistine Chapel to a backyard dog house. Lacking the intricate machinery of living cells, viruses represent biology stripped down to an extreme level. They are the true minimalists of the biological world.

31 Jul 2019

People with obesity get higher level of satisfaction from food, study finds

The propensity to overeat may, in part, be a function of the satisfaction derived from eating. A new study in the Journal of the Academy of Nutrition and Dietetics, published by Elsevier, found no significant difference in taste perceptions between participants of normal weight and those who were overweight.

30 Jul 2019

Whole-genome sequencing could transform salmonella detection

Salmonella is among the most common organisms responsible for symptomatic and serious food poisoning. Methods to detect this have evolved from crude microscopic identification to serotype detection.

29 Jul 2019

Novel therapeutic strategy for treating Lafora Disease shows promise in preclinical study

A team of scientists have designed and tested in mice a novel and promising therapeutic strategy for treating Lafora Disease, a fatal form of childhood epilepsy.

25 Jul 2019

CAR-T cells used to target glioblastoma

Immunotherapy is the new weapon against cancers and building upon existing research, a team of researchers from the Massachusetts General Hospital have devised a way to make immunotherapy more effective in a deadly and common form of brain cancer called glioblastoma.

24 Jul 2019

Researchers identify genes linked to death from sepsis in mice

Sepsis is a life-threatening condition that occurs when the body's immune response to infection spirals out of control.

23 Jul 2019

LexaGene’s beta prototype achieves 98.2% consistency with reference lab data

LexaGene Holdings, Inc., a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today the test results from its first beta prototype placed at the Massachusetts Veterinary Referral Hospital in Woburn, MA. Mass Vet is one of 24 hospitals owned and operated by Ethos Veterinary Health.

15 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019